Complications and Management of VA Shunts: A Case Report
Author Information
Author(s): Nash David L, Schmidt Kevin
Primary Institution: Mayo Clinic
Hypothesis
Should all patients with VA shunts be anticoagulated, to what extent?
Conclusion
Clinically evident and subclinical thromboembolic disease is a known complication of VA shunts, and management is largely undefined.
Supporting Evidence
- The rate of clinically evident pulmonary embolism in patients with VA shunts is only 0.4%.
- Autopsy studies have shown rates of pulmonary embolism as high as 59.7%.
- Long-term anticoagulation is a difficult recommendation to generalize to an asymptomatic population.
Takeaway
This study looks at problems that can happen with a type of medical device called a VA shunt and how to take care of those problems.
Methodology
A literature review of VA shunt complications and long-term management was performed, with consultations from various medical specialties.
Limitations
There is a lack of literature regarding the complications and long-term management of VA shunts.
Participant Demographics
An 18-year-old female with a history of myelomeningocele and hydrocephalus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website